Results 251 to 260 of about 5,996,360 (285)
Some of the next articles are maybe not open access.
European Urology, 2020
OBJECTIVE To present a summary of the 2020 version of the European Association of Urology (EAU)-European Association of Nuclear Medicine (EANM)-European Society for Radiotherapy & Oncology (ESTRO)-European Society of Urogenital Radiology (ESUR ...
P. Cornford +26 more
semanticscholar +1 more source
OBJECTIVE To present a summary of the 2020 version of the European Association of Urology (EAU)-European Association of Nuclear Medicine (EANM)-European Society for Radiotherapy & Oncology (ESTRO)-European Society of Urogenital Radiology (ESUR ...
P. Cornford +26 more
semanticscholar +1 more source
Journal of Urology, 2007
We quantified the burden of prostate cancer in the United States by identifying trends in incidence, disease presentation, survival rates and use of health care resources, and by estimating the economic impact of the disease.The analytic methods used to generate these results were described previously.Age adjusted prostate cancer incidence rates peaked
David F, Penson, June M, Chan
openaire +2 more sources
We quantified the burden of prostate cancer in the United States by identifying trends in incidence, disease presentation, survival rates and use of health care resources, and by estimating the economic impact of the disease.The analytic methods used to generate these results were described previously.Age adjusted prostate cancer incidence rates peaked
David F, Penson, June M, Chan
openaire +2 more sources
Journal of the American Geriatrics Society, 1992
Clinically, prostate cancer (prostatic adenocarcinoma) is now the most frequently diagnosed cancer in males and the second leading cause of mortality due to cancer in the United States. However, because 75% of histologic prostate cancers remain functionally benign (will not metastasize and kill the patient), mass screening of the male population for ...
openaire +2 more sources
Clinically, prostate cancer (prostatic adenocarcinoma) is now the most frequently diagnosed cancer in males and the second leading cause of mortality due to cancer in the United States. However, because 75% of histologic prostate cancers remain functionally benign (will not metastasize and kill the patient), mass screening of the male population for ...
openaire +2 more sources
Southern Medical Journal, 1982
Prostatic cancer is a common cause of morbidity and mortality in the United States. Although many new serologic and radiologic procedures are now used in its diagnosis, the rectal examination still remains the best diagnostic test. Staging is essential for effective treatment.
openaire +2 more sources
Prostatic cancer is a common cause of morbidity and mortality in the United States. Although many new serologic and radiologic procedures are now used in its diagnosis, the rectal examination still remains the best diagnostic test. Staging is essential for effective treatment.
openaire +2 more sources
Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates.
European Urology, 2019CONTEXT Previous studies have reported significant variation in prostate cancer rates and trends mainly due to differences in detection practices, availability of treatment, and underlying genetic susceptibility.
M. Culp +4 more
semanticscholar +1 more source
Granulomatous Prostatitis Mimicking Prostate Cancer
Urology, 2020Multiparametric magnetic resonance imaging plays an important role in the detection of clinically significant prostate cancer. However, there is some overlap between prostate cancer and granulomatous prostatitis. We describe the imaging features of granulomatous prostatitis, which frequently mimics prostate cancer, and differential diagnosis between ...
Sung Kyoung, Moon +2 more
openaire +2 more sources
Nursing Standard, 2014
Essential facts Prostate cancer is the most common cancer in men and makes up 26 per cent of all male cancer diagnoses in the UK. According to the charity Prostate Cancer UK, more than 40,000 men are diagnosed with the disease every year. However, prostate cancer can be slow growing and many men have a cancer that will not cause them harm in their ...
openaire +2 more sources
Essential facts Prostate cancer is the most common cancer in men and makes up 26 per cent of all male cancer diagnoses in the UK. According to the charity Prostate Cancer UK, more than 40,000 men are diagnosed with the disease every year. However, prostate cancer can be slow growing and many men have a cancer that will not cause them harm in their ...
openaire +2 more sources
Prostate cancer — chemoprevention
European Journal of Cancer, 2009Cancer prevention has been sub-classified as follows: • Primary prevention: intervention to prevent the occurrence of cancer in healthy people. • Secondary prevention: intervention in the subclinical phase, no cancer diagnosed, prevent disease in an ‘at risk’ population. • Tertiary prevention: alter the course of minimal clinical disease.
Schröder, Fritz, van Weerden, Wytske
openaire +2 more sources
Prostatitis and prostate cancer: Implications for prostate cancer screening
Urology, 2004Measurement of serum prostate-specific antigen (PSA) levels has become the most important single clinical test in the screening for prostate cancer. The possibility that prostatic inflammation (even in asymptomatic men) may substantially elevate PSA values is an important clinical problem, especially given the vagaries of prostate cancer ...
Jun, Kawakami +2 more
openaire +2 more sources
Comprehensive Therapy, 2005
Prostate cancer is the leading noncutaneous cancer in men of the Western world. Because of its prevalence and ability to cause morbidity and mortality,prostate cancer screening continues to be an important area of focus in health care. This article covers the sensitivity and specificity of prostate-specific antigen and current techniques used to ...
openaire +2 more sources
Prostate cancer is the leading noncutaneous cancer in men of the Western world. Because of its prevalence and ability to cause morbidity and mortality,prostate cancer screening continues to be an important area of focus in health care. This article covers the sensitivity and specificity of prostate-specific antigen and current techniques used to ...
openaire +2 more sources